Editorial
Dried blood spots and HbA1c
First published: 13 August 2020
No abstract is available for this article.
References
- 1Holt RI, Gallen I. Time to move beyond glycosylated haemoglobin. Diabet Med 2004; 21: 655–656.
- 2Hall JM, Fowler CF, Barrett F, Humphry RW, Van Drimmelen M, MacRury SM. HbA1c determination from HemaSpot blood collection devices: comparison of home prepared dried blood spots with standard venous blood analysis. Diabet Med 2020; [DME14110]
- 3Zakaria R, Allen KJ, Koplin JJ, Roche P, Greaves RF. Advantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing Process. EJIFCC 2016; 27: 288–317.
- 4Affan ET, Praveen D, Chow CK, Neal BC. Comparability of HbA1c and lipids measured with dried blood spot versus venous samples: a systematic review and meta-analysis. BMC Clin Pathol 2014; 14: 21.
- 5Verougstraete N, Stove V, Stove C. Comment on HbA1c determination from HemaSpot blood collection devices: comparison of home-prepared dried blood spots with standard venous blood analysis. Diabet Med 2020; 37: 1613–1614.
- 6Hall JM, Fowler CF, Barrett F, Humphry RW, MacRury SM. Reply to Verougstraete et al. Comment on HbA1c determination from HemaSpot blood collection devices: comparison of home-prepared dried blood spots with standard venous blood analysis. Diabet Med 2020; 37: 1614–1615